21 results
UPLOAD
IVVD
Invivyd Inc
16 Jun 21
Letter from SEC
12:00am
factor on page 36, you disclose your reliance
on a sole supplier of
the purification resins and cell culture media and a Chinese CDMO
DRSLTR
IVVD
Invivyd Inc
28 Jun 21
Correspondence regarding draft registration statement
12:00am
, a CDMO in China. In the next risk factor on page 36, you disclose your reliance on a sole supplier of the purification resins and cell culture media
8-K
EX-99.3
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program, November 16, 2023. https://www.federalregister.gov/documents/2023/11
DRS/A
EX-10.7
IVVD
Invivyd Inc
13 Jul 21
Draft registration statement (amended)
12:00am
with the competent Regulatory Authorities a new supplier of the Products. Such obligation of WuXi Biologics shall continue until the earlier of (a) successful … registered with the competent Regulatory Authorities a new supplier of the Products.
20.3 Accrued Rights and Surviving Obligations. Termination
S-1
EX-10.7
5y1lmn45r2ih e2s2
16 Jul 21
IPO registration
4:56pm
10-Q
b6zl5 3x3bu7d88k8w
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.5
f4dohe
20 Sep 21
Quarterly report
4:17pm
DRS
idi76o w7
21 May 21
Draft registration statement
12:00am
S-1/A
jdspmh z7
2 Aug 21
IPO registration (amended)
6:20am
10-K
mnt7v2kkjlt5o3vb
31 Mar 22
Annual report
8:18am
S-1
duxdsbh s016jq
16 Jul 21
IPO registration
4:56pm
DRS/A
jvcmhz o6i
28 Jun 21
Draft registration statement (amended)
12:00am
424B4
4jmu2xsuy
6 Aug 21
Prospectus supplement with pricing info
4:54pm